ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 84 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $80,957 | -54.2% | 83,041 | -25.8% | 0.00% | -100.0% |
| Q1 2024 | $176,884 | +1192.8% | 111,952 | +548.8% | 0.00% | – |
| Q4 2023 | $13,682 | -20.0% | 17,254 | -21.3% | 0.00% | – |
| Q3 2023 | $17,101 | -15.7% | 21,924 | 0.0% | 0.00% | – |
| Q2 2023 | $20,280 | -14.0% | 21,924 | +1.4% | 0.00% | – |
| Q1 2023 | $23,568 | +12.2% | 21,622 | +10.2% | 0.00% | – |
| Q3 2022 | $21,000 | +162.5% | 19,622 | +324.5% | 0.00% | – |
| Q2 2022 | $8,000 | -20.0% | 4,622 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | +150.0% | 4,622 | +391.7% | 0.00% | – |
| Q4 2021 | $4,000 | -20.0% | 940 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | +25.0% | 940 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -20.0% | 940 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | – | 940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 5,555,461 | $4,405,481 | 2.16% |
| MPM BioImpact LLC | 5,095,912 | $4,041,058 | 0.94% |
| NEA Management Company, LLC | 17,079,778 | $13,544,624 | 0.90% |
| Syncona Portfolio Ltd | 1,377,294 | $1,092,194 | 0.69% |
| PFM Health Sciences, LP | 10,423,135 | $8,265,546 | 0.50% |
| TANG CAPITAL MANAGEMENT LLC | 4,387,238 | $3,479,080 | 0.32% |
| Long Focus Capital Management, LLC | 12,086,915 | $9,584,924 | 0.32% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,906,529 | 0.32% |
| Acuitas Investments, LLC | 479,789 | $380,473 | 0.20% |
| Key Client Fiduciary Advisors, LLC | 336,620 | $266,940 | 0.16% |